Centene Corporation reported first‑quarter 2026 revenue of $49.94 billion, up 5% year‑over‑year, and GAAP diluted earnings per share of $3.11. Adjusted diluted EPS rose to $3.37, a 1.5% increase, beating consensus estimates of $1.87–$2.15 and exceeding the company’s prior guidance of $3.20–$3.40.
The revenue lift was driven by a 5% rise in premium and service revenue of $44.66 billion, largely from higher premium yield in the Medicare Prescription Drug Plan (PDP) business. Membership trends showed a decline in Marketplace enrollment to 3.58 million from 5.63 million year‑ago, while Medicaid enrollment remained flat at 12.4 million and Medicare PDP membership grew, offsetting the Marketplace headwind.
Operating margins improved, with the Health Benefits Ratio (HBR) tightening to 87.3% from 87.5% year‑over‑year and the SG&A expense ratio falling to 7.6% from 7.9%. The gains stem from disciplined cost control in Medicaid and Marketplace segments and pricing power in Medicare Advantage, which helped offset the lower Marketplace enrollment.
Management raised its full‑year 2026 adjusted EPS guidance to greater than $3.40, up from the previous $3.20–$3.40 range. The revision reflects confidence in continued margin recovery, sustained Medicare PDP growth, and the impact of a $1.0 billion debt‑repurchase that lowered total debt to $16.4 billion.
The results triggered a positive market reaction, with analysts noting the magnitude of the EPS beat—$1.50 above the median estimate—and the strong guidance. The beat was attributed to effective cost controls and a favorable mix shift toward higher‑margin Medicare segments.
Centene’s performance comes amid a competitive landscape where other managed‑care companies face rising medical costs. The company’s focus on profitability, operational rigor, and strategic debt reduction positions it to sustain growth, especially as Medicare PDP membership continues to expand.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.